CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients
Open Access
- 1 October 2016
- journal article
- Vol. 17 (10) , 4643-4646
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.2016
- Hepatitis B Virus Gene Mutations and HepatocarcinogenesisAsian Pacific Journal of Cancer Prevention, 2013
- CCR5-Delta32 Allele is Associated with the Risk of Developing Multiple Sclerosis in the Iranian PopulationCellular and Molecular Neurobiology, 2009
- Interaction between RANTES Promoter Variant and CCR5Δ32 Favors Recovery from Hepatitis BThe Journal of Immunology, 2008
- Genetic Protection against Hepatitis B Virus Conferred byCCR5Δ32: Evidence that CCR5 Contributes to Viral PersistenceJournal of Virology, 2007
- Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver diseaseJournal of Hepatology, 2006
- Host Absence of CCR5 Potentiates Dendritic Cell VaccinationThe Journal of Immunology, 2003
- Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host diseaseJournal of Clinical Investigation, 1999
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996